Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis Bullosa (CELEB)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03578029 |
|
Recruitment Status :
Terminated
(Business Decision)
First Posted : July 5, 2018
Last Update Posted : August 22, 2022
|
Sponsor:
Lenus Therapeutics, LLC
Information provided by (Responsible Party):
Lenus Therapeutics, LLC
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | September 1, 2021 |
| Actual Study Completion Date : | November 23, 2021 |
| Certification/Extension First Submitted : | August 18, 2022 |